German pharma company acquires University of Basel start-up for 450 million Swiss francs
The biotech company T3 Pharmaceuticals, a spin-off from the University of Basel, is being acquired by the German pharmaceutical company Boehringer Ingelheim. T3 Pharma has developed a novel technol...
unibas.ch